Immune-cell targeted bispecific chimeric proteins and uses thereof
US11246911B2 · kind B2 · utility
3Cited by
12References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 6, 2018 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Jan 9, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to targeted chimeric proteins with beneficial therapeutic effects, including, for example, effects mediated by chimeric proteins which comprise modified signaling agents two or more targeting moieties. Methods of treatment and pharmaceutical compositions comprising the chimeric proteins are also provided. The present invention finds use in the treatment of various disease and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.